CRBP
Ticker
Corbus Pharmaceuticals Holdings, Inc.
CRBP · Healthcare · Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesityCorbus Pharmaceuticals Holdings, Inc. (CRBP), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 5 sales. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Oct 29 and filed Nov 2. The most active filer was Yuval Cohen with 2 filings. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
5
0 buys · 5 sells
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$2.5M
estimated for Congress, as filed for insiders
Median delay
4d
execution to disclosure
Last traded
Oct 29
Filed Nov 2
ADViAverage daily dollar volume
$5.2M
market data
Share price · 12M
$3.07 (-70.7%)
Adjusted for splits and dividends.
Volume by month
Buys $0
Sells $3.2M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
YCRecent filings
Cormorant Asset Management, LPSALE
Other
$1.7M425,000 sh × $4.10
Exec Oct 29
Filed Nov 2 · 4:05 PM ET Yuval CohenSALE Chief Executive Officer $171K
17,000 sh × $10.08
Exec Aug 7
Filed Aug 10 · 4:30 PM ET Sean F. MoranSALE Chief Financial Officer $121K
12,000 sh × $10.08
Exec Aug 7
Filed Aug 10 · 4:30 PM ET Yuval CohenSALE Chief Executive Officer $108K
13,871 sh × $7.78
Exec Feb 13
Filed Feb 18 · 5:30 PM ET Bihua ChenSALE 10% owner $344K
30,029 sh × $11.46
Exec Dec 11 2025
Filed Dec 15 2025 · 5:30 PM ET Sean F. MoranSALE Chief Financial Officer $221K
12,981 sh × $17.02
Exec Oct 24 2025
Filed Oct 27 2025 · 5:30 PM ET Yuval CohenSALE Chief Executive Officer $471K
27,633 sh across 2 lots
Exec Oct 24 2025
Filed Oct 27 2025 · 5:30 PM ET